Corcept Therapeutics is expecting to earn nearly $500 million in revenue this year, which is due in large part…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
People with Cushing’s disease have differences in brain activity that significantly associate with the severity of cognitive and mental…
Cushing’s disease caused by Crooke cell adenoma — a rare but typically more aggressive pituitary tumor — is less…
A woman developed Cushing syndrome after four months of taking supplements that contained a steroid, which she was not aware…
Despite repeatedly testing negative for high cortisol levels on standard lab tests, a woman in her 30s was found to…
A diagnostic test utilizing desmopressin, an artificial form of a hormone that’s used to control excessive thirst and urination and…
Young people with Cushing’s disease who have low bone density also tend to have low levels of insulin-like growth factor…
A woman who developed Cushing’s syndrome as a complication of kidney cancer saw her symptoms fully resolve after the tumor…
An imaging abnormality that makes it harder for clinicians to visualize the brain’s pituitary gland can complicate efforts to diagnose…
Men with Cushing’s syndrome may be at an increased risk of developing anemia (low red blood cell counts) in the…